AstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. Author Correction: Multiparameter prediction of myeloid neoplasia risk (Nature Genetics, (2023), 55, 9, (1523-1530), 10.1038/s41588-023-01472-1)

    Nature Genetics

  2. Multiparameter prediction of myeloid neoplasia risk

    Nature Genetics, Vol. 55, Núm. 9, pp. 1523-1530

  3. Prevalence and significance of DDX41 gene variants in the general population

    Blood, Vol. 142, Núm. 14, pp. 1185-1192

2022

  1. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis

    Nature Genetics, Vol. 54, Núm. 8, pp. 1155-1166

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2006

  1. A suite of parallel vectors for baculovirus expression

    Protein Expression and Purification, Vol. 48, Núm. 2, pp. 173-181